In 2023, Germany's share of scientific publications in Endocrinology, Diabetes, and Metabolism among the world's top 10% cited was at 9.06%. Forecasts indicate a gradual increase reaching 9.12% by 2028, with incremental yearly growth. From 2024 to 2028, the year-on-year growth is minimal, showing a stable yet modest rising trend. The compound annual growth rate (CAGR) over this period is almost flat, reflecting steady performance rather than rapid growth.
Future trends to watch for include technological advancements in research methodologies, the potential impact of public policies on healthcare research funding, and the growing interconnections within the global research community, which might help further increase Germany’s representation in high-impact scientific literature.
